DoJ Investigation Of Renal Care Includes Pharma Company Relationships
This article was originally published in The Pink Sheet Daily
The subpoena is similar to those received by three other top dialysis services providers, Renal Care says.
You may also be interested in...
Both dialysis firms have been asked to produce documents related to vitamin D therapies and testing for parathyroid hormone levels. DaVita is requesting a meeting with DoJ to discuss the scope of the subpoena and the production of documents.
The company will pay up to $355 mil. to settle a Medicare billing fraud civil suit initiated by the Department of Justice. Gambro is absolved of claims against a dialysis supply subsidiary in exchange for a guilty plea to a single felony charge.
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability